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MinireviewA New Trigger for T Cells
in a high state of readiness to respond to the appropriateMark M. Davis1
foreign antigen when it comes along.Howard Hughes Medical Institute and
For many years it has been thought that the principalDepartment of Microbiology and Immunology
trigger for T cell activation is the tyrosine phosphoryla-Stanford University School of Medicine
tion of CD3 molecules, particularly CD3, brought aboutStanford, California 94305
by TCR crosslinking and mediated by lck (Weiss 1999).
The recent report of Alarcon and colleagues (Gil et al.,
2002) adds a new and unexpected element to the story,Understanding the early events in T cell activation and
with a very strong case for an additional and slightlysignaling is an active area of research. A recent study
earlier triggering event involving a conformational(Gil et al., 2002) has described a new trigger for T cell
change and subsequent exposure of a proline-rich re-activation, involving a TCR-ligand-induced conforma-
gion of the cytoplasmic tail of CD3. Exposure of thistional change in CD3 that permits binding of the adap-
region allows the adaptor protein Nck to bind. Theytor protein Nck.
demonstrate that this can occur in isolated TCR-CD3
complexes, even, surprisingly, with stimulation by mon-T cell recognition is a central part of the immune re-
valent antibodies, and that it seems completely indepen-sponse to foreign entities. Mediating this recognition
dent of early tyrosine phosphorylation. The associationare T cell receptor (TCR) heterodimers, which are like
of Nck to CD3 appears to be necessary for proper Tantibodies in their ability to create vast numbers of dif-
cell activation, as a dominant negative construct of Nckferent variable (V) region sequences through DNA re-
inhibits the ability of T cells to form conjugates to otherarrangement and other mechanisms (Davis et al., 1998).
cells in response to antigen, and disrupts aspects ofUnlike antibodies, T cell receptors always remain on
synapse formation, cytoskeletal reorganization, and cy-the cell surface, and the major species,  type TCRs,
tokine production. Thus, it appears that there are atrecognize specific fragments of antigens (peptides)
least two distinct pathways whereby TCR engagementbound to major histocompatibility complex (MHC) mole-
triggers activation in T cells: tyrosine phosphorylationcules and displayed on the surfaces of other cells. This
of ITAMs by Lck and Fyn, and a conformational changeability to survey degradation products of antigens
in CD3 leading to Nck recruitment, with both of thesemakes for a detection system that is intrinsically difficult
occurring within seconds of TCR engagement with li-for pathogens to avoid, as all proteins must eventually
gand. These signals probably converge at some pointbe degraded. It is also an extremely sensitive system,
downstream, with a likely point of convergence beingas very few peptide-MHC complexes on an antigen-
the signaling molecule SLP-76. SLP-76 is an adaptorpresenting cell are needed to trigger a T cell response.
protein which is essential for T cell activation, reportedlyIn order to understand how engagement of the TCR to
binding to Nck, ZAP-70, and Vav (a guanine nucleotidea ligand activates a T cell, attention has long focused
exchange factor) (Lin and Weiss, 2001).on the CD3 molecules (CD3, , , and ) which are
Possible Mechanismsassembled together with the TCR heterodimer and pos-
What exactly happens to CD3 to expose the prolinesess a characteristic sequence motif for tyrosine phos-
rich region to Nck binding is not clear. Structural infor-phorylation, known as ITAMs (Reth, 1989). The TCR
mation on the CD3 molecules is very sparse (Sun et
polypeptides themselves have very short cytoplasmic
al., 2001) and only pertains to the external domains.
tails, and it appears that all proximal signaling events
Interestingly, Stern and colleagues (Aivazian and Stern,
are mediated through the CD3 molecules. As shown in 2000) found that in a lipid environment, the cytoplasmic
Figure 1A, they are organized in dimeric units (CD3, region of CD3 is helical, but that it becomes disordered
CD3, and CD3) (Terhorst et al., 1996), and evidence when phosphorylated. They have proposed that this is
also indicates that there are two TCR heterodimers per a trigger for activation, but there is as yet no evidence
unit (Fernandez-Miguel et al., 1999, Terhorst et al., 1996). of this happening within a cell. Gil et al. propose that
The variety and apparent redundancy of these polypep- TCR engagement induces a conformational change in
tides probably relate to the varying signals that a T cell CD3 that allows Nck binding and show that the binding
must receive in order to mature and survive. In particular, of some antibodies, but not others, to TCR-CD3 exposes
immature T cells are heavily selected in the thymus both the Nck binding site on isolated complexes. One caution
for a successful TCR  rearrangement (the pre-TCR- that should be stated here about these experiments is
CD3 complex) and later for complete  TCRs which that exposure to the natural ligand (peptide-MHC) is
react weakly to self-peptide-MHC complexes, which is not used here, but rather, anti-CD3 antibodies and Fab
important for avoiding selection of self-reactive T cells. fragments of the antibodies are used as the stimulus.
The selected T cells then require additional stimulation At least one of these antibodies is directed against CD3
in the periphery from such ligands in order to survive. directly, and this may enhance the effect seen. Still, in
This selection and maintenance process is apparently other experiments, Gil et al. show that the exposure of
necessary to establish a TCR repertoire that is both TCR transgenic mouse T cells to antigen-pulsed pre-
predisposed toward a particular MHC complement and senting cells promotes Nck binding to the TCR/CD3
complex, which helps to allay concerns about the artifi-
ciality of the antibody induction. It should also be noted1Correspondence: mdavis@cmgm.stanford.edu
Cell
286
Figure 1. Models for the Organization of
TCR/CD3
(A) Approximate organization of TCR/CD3
subunits from Terhorst et al. (1996) and Fer-
nandez-Miguel et al. (1999), incorporating the
concept that the cytoplasmic domains of
some or all of the CD3 chains are stabilized
into a helical conformation by their proximity
to the plasma membrane (Aivazian and Stern,
2000; Gil et al., 2002).
(B) Postulated ligand engagement may
change the relationship of both CD3 and 
cytoplasmic regions, exposing them to the
src kinases Lck and Fyn and Nck interaction,
respectively. This may occur by either a pis-
ton-like conformational movement or a me-
chanical displacement of the entire complex
inward because of T cell pressure on the anti-
gen-presenting cell, or both.
that attempts to trigger even the most sensitive helper against the surface of the antigen-presenting cell. This
could augment a “piston” mechanism, in which all orT cells with monovalent ligands have been unsuccessful
(Cochran et al., 2000; Boniface et al., 1998), with only part of the TCR-CD3 complex is displaced into the mem-
brane. This possibility is summarized in Figure 1B, whichdimers or trimers of peptide-MHC being effective. Thus,
while the triggering pathway described by Gil et al. may draws on the findings of Gil et al., as well as the prior
speculations of Otteman et al. (1999), Aivazian and Sternbe necessary for complete T cell activation, it doesn’t
appear to be sufficient. As the authors discuss, this (2000), and Sun et al. (2001). Alternatively, ligand binding
has been seen to induce very large allosteric changesfinding is in apparent contradiction to structural data
showing that no conformational changes in the mem- in a number of receptor complexes, including the anatur-
etic peptide receptor (He et al., 2001) and a bacterialbrane proximal portion of the TCR occur with binding
(as reviewed by Rudolph and Wilson, 2002), although ribose binding protein (Mowbray and Bjorkman 1999).
So, perhaps changes of this sort can be induced in CD3changes in the binding site can be considerable (Reiser
et al., 2002, Wu et al., 2002). Still, there are precedents molecules by some movement or rotation of the TCR
upon ligand binding that is not readily apparent from thein other receptor systems where ligand engagement
changes the relationship between components. As dis- liganded and unliganded structures of the extracellular
portion, but that somehow changes its relationship tocussed by Gil et al., following earlier suggestions by
Sun and colleagues (Sun et al., 2001), one attractive the CD3 molecules. Another possibility is that slowing
the lateral mobility of the TCR through binding to itspossibility comes from the work of Otteman et al. (1999),
who showed by spin labeling that the rod-like extracellu- ligand embedded in another membrane might change
its lipid environment and that of the CD3 moleculeslar components of the aspartate receptor move in a
piston-like fashion upon ligand binding. While the dis- associated with it (van der Merwe, 2001).
In summary, Gil and colleagues describe a completelyplacement was small (approximately 1 A˚), it might be
larger in the case of TCR/CD3 complexes and change new pathway in T cell activation, and trace it directly to
a little-understood member of the TCR/CD3 complex,the relationship of the cytoplasmic domains of CD3
with respect to the membrane. Although not very similar CD3. This pathway seems entirely independent of the
aggregation-dependant tyrosine-phosphorylation ofin terms of sequence with CD3, if the effect seen by
Aivazian and Stern (2000) for CD3 has relevance for CD3 molecules, at least in its early stages, which up
until now has been thought to be the principle triggerCD3, then its displacement with respect to the mem-
brane might radically change its structure and promote of cellular activation. Hopefully we will learn, in the not-
so-distant future, the precise structural and dynamicNck binding. It is also possible that the relatively low
affinity (micromolar) of TCR ligand interaction is not suf- relationships between the molecules of this large recep-
tor/signaling complex, and how the different compo-ficient to induce CD3 exposure, and it also requires
some mechanical force on the part of the T cell, pressing nents change upon ligand binding, as well as the subtle
Minireview
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(or perhaps not so subtle) variations that may occur
during T cell development and in peripheral mainte-
nance.
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